# BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q2 Balance Sheet

- Company: BOSTON SCIENTIFIC CORPORATION (BSX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-03, accession number 0000885725-26-000053
- Page: https://plicit.ai/financials/bsx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/bsx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 45,216,000,000 US dollars
- **Current assets**: 7,972,000,000 US dollars
- **Non-current assets**: 37,244,000,000 US dollars
- **Liabilities (calculated)**: 20,044,000,000 US dollars
- **Current liabilities**: 6,428,000,000 US dollars
- **Non-current liabilities**: 13,616,000,000 US dollars
- **Equity**: 25,172,000,000 US dollars
- **Noncontrolling interest**: 242,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Inventories**: 3,235,000,000 US dollars
- **Trade accounts receivable, net**: 3,049,000,000 US dollars
- **Other current assets**: 760,000,000 US dollars
- **Cash and cash equivalents**: 539,000,000 US dollars
- **Prepaid income taxes**: 390,000,000 US dollars
- **Goodwill**: 18,640,000,000 US dollars
- **Other intangible assets, net**: 6,918,000,000 US dollars
- **Property, plant and equipment, net**: 4,126,000,000 US dollars
- **Deferred tax assets**: 3,909,000,000 US dollars
- **Other investments**: 2,245,000,000 US dollars
- **Other long-term assets**: 1,405,000,000 US dollars
- **Accrued expenses**: 2,756,000,000 US dollars
- **Current debt obligations**: 1,709,000,000 US dollars
- **Accounts payable**: 1,231,000,000 US dollars
- **Other current liabilities**: 732,000,000 US dollars
- **Long-term debt**: 10,915,000,000 US dollars
- **Other long-term liabilities**: 2,480,000,000 US dollars
- **Deferred tax liabilities**: 221,000,000 US dollars
- **Additional paid-in capital**: 21,717,000,000 US dollars
- **Retained earnings**: 7,818,000,000 US dollars
- **Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,917,975 shares issued as of June 30, 2026 and 1,746,290,165 shares issued as of December 31, 2025**: 17,000,000 US dollars
- **Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of June 30, 2026 and December 31, 2025**: 0 US dollars
- **Noncontrolling interests**: 242,000,000 US dollars
- **Treasury stock, at cost - 303,212,284 shares as of June 30, 2026 and 263,289,848 shares as of December 31, 2025**: negative 4,318,000,000 US dollars
- **Accumulated other comprehensive income (loss), net of tax**: negative 304,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed current assets lines add up to $7,973.00 M and the current assets total is $7,972.00 M; the $1.00 M difference is within the rounding of the filed amounts.
- The filed non-current assets lines add up to $37,243.00 M and the non-current assets total is $37,244.00 M; the $1.00 M difference is within the rounding of the filed amounts.